Edition:
United States

Michael Shields

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Jun 27 2018

Hardening attitudes to migrants put Swiss-EU ties to the test

ZURICH Marco Bueter, a gastric surgeon from Germany, knows from his work at University Hospital Zurich and other clinics how much Switzerland depends on foreign doctors.

Jun 19 2018

Roche pays $2.4 billion for rest of cancer expert Foundation Medicine

ZURICH/LONDON Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine (FMI) , raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.

Jun 13 2018

Swiss signal labor rule flexibility in EU treaty talks

ZURICH Switzerland is prepared to take a flexible approach to labor market rules in talks with the European Union on a new treaty, Foreign Minister Ignacio Cassis said, signaling movement on a potential stumbling block for any deal.

Jun 08 2018

Swiss prepare to strike at EU bourses in treaty row

ZURICH The Swiss government threatened on Friday to ban trading of Swiss shares on exchanges in the European Union in a tit-for-tat battle with Brussels over stock market rules that could put a severe dent in cross-border trading.

May 09 2018

Zurich Insurance plays down M&A talk as first quarter premiums beat

ZURICH/LONDON Zurich Insurance has no plans for a big merger, it said on Wednesday, despite speculation of a pick-up in dealmaking in the industry and that the Swiss company could get involved.

May 03 2018

Roche wins reprieve as Novartis biosimilar delayed in U.S.

LONDON/ZURICH Roche has won a reprieve from an expected wave of cheaper versions of its biotech cancer drugs as U.S. regulators knocked back a biosimilar form of rituximab from Swiss rival Novartis.

Mar 28 2018

Swiss revive plan to support newer EU members as ties thaw

ZURICH Switzerland revived plans on Wednesday to contribute an extra 1.3 billion Swiss francs ($1.4 billion) for newer European Union members as relations with its biggest trading partner began improving after a spat at the end of last year.

Mar 28 2018

Swiss revive plan to support new EU members as ties thaw

ZURICH, March 28 Switzerland revived plans on Wednesday to contribute an extra 1.3 billion Swiss francs ($1.37 billion) in funds for newer European Union members as relations with its biggest trading partner began improving after a spat at the end of last year.

Mar 27 2018

Cyber-attacks biggest risk for Swiss banks: watchdog

BERN Cyber-attacks pose the biggest threat to the Swiss financial system with risks from hacking incursions on the rise, watchdog FINMA warned on Tuesday, calling on Switzerland to step up its national defenses against the menace.

Mar 14 2018

Switzerland faces law change call to return 1MDB profits to Malaysia

BERN Swiss lawmakers are pushing the government to amend the law on how to handle ill-gotten bank profits seized by authorities and pave the way to return more than $100 million linked to scandal-hit sovereign fund 1MDB to the Malaysian people.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary